Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - neoplazme dojke - antineoplastična sredstva - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

pfizer europe ma eeig - somatrogon - growth and development - hipofiza in hypothalamic hormoni in analogi - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - sevelamer - filmsko obložena tableta - sevelamer 800 mg / 1 tableta - sevelamer

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

altamedics d.o.o. - hidrokortizon - tableta - hidrokortizon 10 mg / 1 tableta - hidrokortizon

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aspen pharma trading limited - natrijev levotiroksinat - tableta - natrijev levotiroksinat 100 mg / 1 tableta - natrijev levotiroksinat

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

pfizer limited - insulin human - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - exubera je indiciran za zdravljenje odraslih bolnikov z diabetesom tipa 2, bolezni notadequately nadzira z ustno antidiabetic sredstva in potrebujejo insulin terapija. exubera je prikazano tudi za zdravljenje odraslih bolnikih s tipom 1 sladkorne bolezni, inaddition za dolgo ali vmesne deluje podkožnega insulina, za katere potencialne koristi ofadding pri vdihavanju insulina odtehtajo morebitne pomisleke glede varnosti (glej poglavje 4.

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

mylan pharmaceuticals limited - fulvestrant - neoplazme dojke - endokrini terapija - fulvestrant je primerna za zdravljenje estrogen receptor pozitivno, lokalno napredno ali metastatskega raka dojke pri ženskah po menopavzi:ne prej, zdravljenih z endokrinih terapije, orwith ponovitve bolezni na ali po adjuvant anti-estrogen terapije, ali napredovanja bolezni na antiestrogen terapija.

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - macimorelin acetat - diagnostične tehnike, endokrine - macimorelin - to zdravilo je samo za diagnostično uporabo.  ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.

Umoja wa Ulaya - Kislovenia - EMA (European Medicines Agency)

diurnal europe b.v. - hidrokortizon - adrenal hyperplasia, congenital - kortikosteroidi za sistemsko uporabo - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.

Slovenia - Kislovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

bayer d.o.o. - estradiol - transdermalni obliž - estradiol 3,8 mg / 1 obliž - estradiol